BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
12/14/2018 3:36:55 AM | Browse: 897 | Download: 2255
 |
Received |
|
2018-05-23 00:58 |
|
Peer-Review Started |
|
2018-05-25 00:11 |
|
First Decision by Editorial Office Director |
|
2018-07-09 06:09 |
|
Return for Revision |
|
2018-07-10 08:21 |
|
Revised |
|
2018-09-07 07:34 |
 |
Publication Fee Transferred |
|
|
|
Second Decision by Editor |
|
2018-11-01 02:24 |
|
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2018-11-03 04:50 |
|
Articles in Press |
|
2018-11-03 04:50 |
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2018-11-26 06:20 |
|
Publish the Manuscript Online |
|
2018-12-14 03:36 |
| ISSN |
2220-3230 (online) |
| Open Access |
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2018. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Transplantation |
| Manuscript Type |
Retrospective Cohort Study |
| Article Title |
Graft vs host disease impacts overall survival post allogeneic hematopoietic stem cell transplantation for acute lymphoblastic leukemia/lymphoma
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Moussab Damlaj, Mohammad Snnallah, Ayman Alhejazi, Samer Ghazi, Bader Alahmari, Ahmed Alaskar and Mohsen Alzahrani |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Moussab Damlaj, FACP, FRCP (C), MD, Assistant Professor, Doctor, Doctor, Division of Hematology and HCT, Department of Oncology, King Abdulaziz Medical City, P.O. Box 22490, Riyadh 11426, Saudi Arabia. damlajmo@ngha.med.sa |
| Key Words |
Acute lymphoblastic leukemia; Allogeneic hematopoietic stem cell transplant; Lymphoblastic lymphoma; Complete remission |
| Core Tip |
Allogeneic hematopoietic stem cell transplantation (HCT) is a potentially curative therapy for acute lymphoblastic leukemia/lymphoma (ALL/LBL) patients. We examined the outcome and prognostic factors of HCT for high risk ALL/LBL at our center. After due institutional review board approval, 69 patients were enrolled. After a median follow up of 15 mo (2-87.3), the 2-year overall survival (OS) was 62.8%. In a multivariable analysis; B-cell subtype, first complete remission status, acute graft vs host disease (GVHD) and chronic GVHD predicted OS. In conclusion, allogeneic-HCT for ALL/LBL results in promising remissions in high risk disease and early referral for HCT to be considered for young and fit patients. |
| Publish Date |
2018-12-14 03:36 |
| Citation |
Damlaj M, Snnallah M, Alhejazi A, Ghazi S, Alahmari B, Alaskar A, Al-Zahrani M. Graft vs host disease impacts overall survival post allogeneic hematopoietic stem cell transplantation for acute lymphoblastic leukemia/lymphoma. World J Transplant 2018; 8(7): 252-258 |
| URL |
http://www.wjgnet.com/2220-3230/full/v8/i7/252.htm |
| DOI |
http://dx.doi.org/10.5500/wjt.v8.i7.252 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.
